Upper Resp Tract Infection
9
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Evaluation of a Hypertonic Seawater Aerosol Therapy Solution in Adults and Children
Community Interventions for Tackling Antimicrobial Resistance in Ghana
CHAO Tos: Codeina, HederA Helix, LevOdropropizina Para la TOS
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
A Study to Assess the Effect of a Probiotic on Upper Respiratory Tract Infections in Healthy Children
Urgent Care Management of Respiratory Illness Enabled With Novel Testing Pathway
COVID-19 Pandemic Response Network
TEM-PCR™ Prospective Clinical Utility Study
Prospective Clinical Evaluation of the FilmArray Respiratory Panel 2